Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of...
Source: PM360
- Featured Article
Central monitoring is highly effective in detecting emerging quality issues in clinical trials, but debate continues...
Source: Applied Clinical Trials
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
The need to boost education, shift culture, and embrace new technologies.
...Source: Applied Clinical Trials
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Featured Article
As an industry, we regularly discuss the benefits of adopting risk-based quality management (RBQM). The good...
Source: International Clinical Trials/European Pharmaceutical Contractors
- Featured Article
François Torche dispels the myth that, at least in RBQM, there is such a thing as...
Source: PM360
- Featured Article
An increase in clinical trial data is driving demand for enhanced clinical trial processes. Sponsors want...
Source: Journal for Clinical Studies
- Featured Article
With increasing pressure to overcome drug development challenges and advance drugs to market faster and with...
Source: Contract Pharma
- Featured Article
Today’s drug development landscape demands contract research organizations (CROs) provide flexible models that leverage the latest...
Source: Contract Pharma
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM)...
- Press Release
Cambridge, MA – FDA and its stakeholders have an interest in assuring the integrity of clinical...
- Press Release
We’re delighted to announce that are our next Risk-Based Monitoring implementation webinar is open for registration!...
- Press Release
The CluePoints and OmniComm Risk-Based Monitoring Implementation Roadshow is Coming to a City Near You! In...
- Press Release
We’re thrilled to announce that CluePoints is now offering a complimentary Risk-Based Monitoring strategy Check-up and...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has...
- Press Release
We’re thrilled to announce that CluePoints’ latest version (1.9.0) of the Central Monitoring platform is live!...
- Press Release
The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop is fast approaching and we’re thrilled to announce that...
- Press Release
Today, we’re thrilled to unveil CluePoints’ latest release of its award-winning Risk-Based Monitoring Software. For this...
- Press Release
Join CluePoints CEO Francois Torche and OmniComm Sr. Director Steve Young at this special thought leadership...
- Press Release
Awards recognize CluePoints’ Risk-Based Monitoring solution in the ‘Best Sponsor-Focused Technological Development’ category. Cambridge, MA –...
- Featured Article
Safety reporting is a critical aspect of clinical trial quality, directly impacting patient safety and regulatory...
Source: Applied Clinical Trials
- Featured Article
In clinical trials, every second counts, both for patient outcomes and sponsor ROI. As data volumes...
Source: Clinical Research News
- Featured Article
The theme for this year’s International Women’s Day (IWD) on 8th March was ‘Give to Gain’....
Source: Pharmaphorum
- Featured Article
Quality tolerance limits (QTLs) are trial-level thresholds on critical-to-quality (CtQ) factors—key measures where sustained deviation could...
Source: Applied Clinical Trials
- Featured Article
Risk-based quality management (RBQM) is becoming central to clinical trial oversight, with ICH E6(R3) emphasising proportional,...
Source: Discover Pharma
- Featured Article
Analysis of more than 880 clinical trials shows that while statistical data monitoring and key risk...
Source: Applied Clinical Trials
- Featured Article
As AI finds solid footing in pharma R&D, the technology is slated to yield significant rewards....
Source: PharmaVoice
- Featured Article
To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News...
Source: Clinical Research News
- Featured Article
Dan Beaudry, market owner for risk-based quality management (RBQM) at CluePoints, explains how regulatory shifts and...
Source: Discover Pharma
- Featured Article
Returning to the series is CluePoints, with Sophie Henderson, senior strategic consultant, sharing her hopes and...
Source: Discover Pharma
- Featured Article
Regulatory changes, including the launch of ICH E6(R3) and Good Clinical Practice (GCP) updates, have highlighted...
Source: International Pharmaceutical Industry
- Featured Article
Sophie Henderson, Senior Strategic Consultant at CluePoints, said: “This year we have seen risk-based quality management...
Source: Discover Pharma